[Related Content] In a large real-world study of more than 125,000 adults published in JAMA Network Open , nearly two-thirds of patients using GLP-1s specifically for weight loss discontinued treatment within the first year
This article will explore possible reasons for this phenomenon, examining medical, physiological, and lifestyle factors that could be affecting your progress
Consider this initial period of time a ramp-up
Advances in point-of-care testing, such as gastric ultrasonography, will be incredibly beneficial in mitigating the possible negative consequences of these medications perioperatively
However, in the presence of chronic viral persistence or high levels of inflammatory cytokines, the muscle cells become "deaf" to these normal signals